Cadexomer Iodine Gel Suppliers & Bulk Manufacturers
Available Forms: Gel
Available Strengths: 500 mg
Reference Brands: Iodosorb Gel (USA/EU), Iodoflex Gel (EU/Asia)
Category:
Wound Care
Cadexomer iodine gel is available in Gel
and strengths such as 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cadexomer iodine gel is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cadexomer iodine gel can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Iodine-based wound care products, including cadexomer iodine (CI) and povidone iodine (PI), are widely used to manage chronic, infected, or non-healing wounds. Both formulations provide antimicrobial activity, helping to minimize bacterial contamination and promote a clean wound environment. PI offers broad-spectrum antiseptic and anti-inflammatory properties, low cytotoxicity, and good tolerability, with minimal risk of bacterial resistance. It is effective for cleansing wounds and supporting tissue repair.
Cadexomer iodine, on the other hand, consists of iodine immobilized within a hydrophilic modified-starch polymer bead. This structure allows CI to both absorb exudate, effectively cleansing the wound, and deliver sustained bactericidal activity over time. The dual properties of CI help reduce wound bioburden, promote granulation tissue formation, and support wound closure in chronic ulcers, burns, and other complex wounds.
Both CI and PI dressings have demonstrated efficacy in reducing biofilm formation, decreasing wound size, and enhancing granulation tissue, although outcomes vary depending on the preparation and clinical context. These iodine-based therapies remain essential tools in modern wound care, offering clinicians flexible, safe, and effective options to manage infection and support optimal healing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing